|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 583 active entries
Willem Schoutenstraat 1
1057 DL Amsterdam The Netherlands
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
MRC Holland is the inventor and manufacturer of Multplex-ligation dependent Probe Amplification, or MLPA. MLPA® is a method that can detect copy number changes of up to 50 nucleic acid sequences in one simple reaction. MLPA® quickly identifies amplifications and deletions of a large number of genes, and can be used for DNA and mRNA profiling of both blood and tumour-derived samples. Furthermore, the MLPA® method can also be used to analyse CpG-methylation (MS-MLPA®). MLPA® has rapidly established its reputation as a trustworthy and efficient method. Hundreds of publications about the technique have appeared since its introduction in 2002, and MLPA® is now used in more than 900 laboratories worldwide.
Last update of this entry: September 29, 2015